Slide background


DeepView™ Wound Imaging System

The key to the Spectral MD DeepView Wound Imaging System is systems–based technology that combines real–time digital analysis of optical signatures to sensitize an imager to photon–tissue interactions below the skin's surface.  These image signatures relate directly to a patient's dynamic physiology – both in terms of the quantity and quality of important properties such as blood flow and tissue composition.  In the clinical study setting, the DeepView device has produced images that reflect key operational parameters of the human system for review by clinicians. With an extended mechanical arm, the device can be positioned precisely over any area of the body, and results are rapidly delivered in real-time. Most importantly, the technology does not contact the patient nor emit any harmful radiation.


The First Generation DeepView Wound Imaging System has received FDA 510(k) clearance for sale in the U.S.A, and the DeepView Wound Imaging System 2.0 is currently under investigation in IRB-controlled clinical study environments.


Please contact Spectral MD for more information on the most up-to-date regulatory status of the DeepView Wound Imaging System, including future generation devices, and availability in other worldwide markets.